| Literature DB >> 35038580 |
Chen Yang1, Siqi Wu2, Zezhong Mou2, Quan Zhou2, Xiyu Dai2, Yuxi Ou2, Xinan Chen2, Yiling Chen2, Chenyang Xu2, Yun Hu2, Limin Zhang2, Lujia Zou2, Shengming Jin3, Jimeng Hu4, Shanhua Mao5, Haowen Jiang6.
Abstract
Circular RNAs (circRNAs) play critical roles in different diseases. Exosomes are important intermediates of intercellular communication. While both have been widely reported in cancers, exosome-derived circRNAs are rarely studied. In this work, we identified the differently expressed circRNAs in bladder cancer (BCa) tissue and exosomes through high-throughput sequencing. RNA pull-down, RNA immunoprecipitation, and luciferase reporter assays were used to investigate the interactions between specific circRNAs, microRNAs (miRNAs), and mRNAs. Wound-healing, Transwell, Cell Counting Kit-8 (CCK8), and colony-formation assays were used to study the biological roles in vitro. Metabolomics were used to explore the mechanism of how specific circRNAs influenced BCa cell behavior. Flow cytometry was used to study how specific circRNAs affected the function of CD8+ T cells in tumor microenvironments. We identified that exosome-derived hsa_circ_0085361 (circTRPS1) was correlated with aggressive phenotypes of BCa cells via sponging miR-141-3p. Metabolomics and RNA sequencing (RNA-seq) identified GLS1-mediated glutamine metabolism was involved in circTRPS1-mediated alterations. Exosomes derived from circTRPS1 knocked down BCa cells, prevented CD8+ T cells from exhaustion, and repressed the malignant phenotype of BCa cells. In conclusion, exosome-derived circTRPS1 from BCa cells can modulate the intracellular reactive oxygen species (ROS) balance and CD8+ T cell exhaustion via the circTRPS1/miR141-3p/GLS1 axis. Our work may provide a potential biomarker and therapeutic target for BCa.Entities:
Keywords: CD8+ T cell; ROS; bladder cancer; circular RNAs; exosomes; tumor microenvironment
Mesh:
Substances:
Year: 2022 PMID: 35038580 PMCID: PMC8899700 DOI: 10.1016/j.ymthe.2022.01.022
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454